AI assistant
Sending…
Medtronic plc — Director's Dealing 2016
Mar 22, 2016
29841_dirs_2016-03-22_4e320412-787d-42e6-9ac9-32ab3ba2adec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-03-18
Reporting Person: JACKSON SHIRLEY A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-18 | Ordinary Shares | S | 1238 | $75.60 | Disposed | 29812 | Direct |
| 2016-03-18 | Ordinary Shares | M | 1493 | $46.91 | Acquired | 31305 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-18 | Stock Option (Right to Buy) | $46.91 | M | 1493 | Disposed | 2016-09-01 | Ordinary Shares (1493) | Direct |
Footnotes
F1: This balance increased by 450 shares due to exempt transactions such as dividend reinvestment.
F2: This option to purchase 1,493 ordinary shares of New Medtronic for $46.91 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,493 Medtronic common stock shares for $46.91 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option
More from Medtronic plc
Report Publication Announcement
2026
Jun 3
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Earnings Release
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29